Skip to main content

A cohort for type 2 diabetes studies

Nov. 17, 2020, 8:00 AM

by Leigh MacMillan

Electronic medical record data collected for clinical care may be valuable for studies of long-term outcomes in “real-world” populations. 

Katherine N. Bachmann, MD, MSCI, and colleagues examined the National Patient-Centered Clinical Research Network (PCORnet) as a resource for studies of patients with type 2 diabetes. PCORnet is a national, distributed research network of interconnected health care data systems. 

The investigators identified a retrospective cohort of 613,203 adult patients with type 2 diabetes and characterized prescription patterns, clinical characteristics and medical comorbidities. In the cohort, 42% had a single type 2 diabetes drug class prescription and 15% were prescribed multiple type 2 diabetes drug classes. 

The PCORnet population offers advantages over existing type 2 diabetes cohorts including greater gender, racial and geographic diversity. The report in Pharmacology Research & Perspectives supports further validation of the PCORnet cohort and suggests that it may be valuable for assessing the cardiovascular safety of type 2 diabetes drugs, a priority research area.

This research was supported by the Department of Veterans Affairs, Patient-Centered Outcomes Research Institute, PhRMA Foundation, Vanderbilt University Medical Center, and the National Institutes of Health (grants TR002489, DK098246, DK108612, DK118612, GM104940). 

Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
VUMC Voice